See all
 |
Articles: Drug Approvals |
Prior Articles
Teva Announces Approval And Launch Of Generic Urso 250 And Urso Forte
Teva Pharmaceutical Industries, 05/15/09
Free full text
Genentech to Present Advances With Targeted Cancer Medicines at ASCO
Genentech, 05/15/09
Free full text
Medtronic Demonstrates Positive Results on First Pacemaker Designed for Use with MRI
Medtronic, 05/15/09
Free full text
Novartis receives approval from FDA to market Prevacid 24HR as first and only OTC proton pump inhibitor in original prescription formulation
Novartis, 05/15/09
Free full text
UCB"s Cimzia Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology--
Enzon Pharmaceuticals, 05/15/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/14/09
Free full text
FDA Approves ACTOplus met XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals North America, 05/14/09 Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Boston Scientific, 05/13/09
Free full text
Medtronic to Seek Indication Expansion for Heart Failure Device Therapy
Medtronic, 05/13/09
Free full text
Corporate Governance
Patheon, 05/13/09 Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/12/09
Free full text
FDA Approves Drug for Treatment of Aggressive Brain Cancer
FDA Press Releases, 05/11/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/11/09
Free full text
FDA Approves Pancreatic Enzyme Replacement Product for Marketing in United States
FDA Press Releases, 05/08/09
Free full text
Glivec approved in EU as first post-surgery therapy to reduce risk of cancer returning in patients with aggressive gastrointestinal tumors
Novartis, 05/08/09
Free full text
Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept
Mylan, 05/08/09 Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer
Roche, 05/07/09
Free full text
FDA Approves New Influenza Vaccine Production Facility
FDA Press Releases, 05/07/09
Free full text
Medtronic Completes Early Enrollment in U.S. Study of Endurant Abdominal Aortic Stent Graft
Medtronic, 05/07/09
Free full text
FDA Approves New Medtronic Left Heart Lead for Cardiac Resynchronization Therapy Devices
Medtronic, 05/07/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|